ARENA: GOOD TRIAL RESULTS FROM THIS BIOTECH, OVER 400% GAIN POSSIBLE IN A BUYOUT $ARNA
This post was just published on ZYX Buy Change Alert. Arena stock (ARNA) is long from $16.20. ARNA is trading at $40.75 as of this writing, up $9.86 for the day. It has traded as high as $44.44. The company reported impressive results from a Phase II trial of its ulcerative colitis drug. Previously